Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 10:05 ET | Source: Nucleus Genomics Inc.

Nucleus Brings Genetic Optimization to India and the Middle East Through Leading IVF Networks

Nucleus announces joint ventures with Indira IVF and the Abu Ghosh Fertility Group, bringing their advanced genetic screening to India and the Middle East.
March 26, 2026 10:05 ET | Source: Nucleus Genomics Inc.

Nucleus מביאה אופטימיזציה גנטית להודו ולמזרח התיכון באמצעות רשתות IVF מובילות

ניו יורק, March 26, 2026 (GLOBE NEWSWIRE) -- חברת Nucleus Genomics הכריזה היום על מיזמים משותפים עם Indira IVF, ספקית שירותי הפריה חוץ גופית הגדולה ביותר בהודו, ועם קבוצת Abu Ghosh Fertility, אחת...
March 26, 2026 09:45 ET | Source: Novonesis (Novozymes A/S)

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
March 26, 2026 09:27 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient

RAMAT GAN, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs...
March 26, 2026 09:23 ET | Source: Sironax USA, Inc.

更正 -- 維泰瑞隆宣佈委任王舒展先生為董事會董事

馬薩諸塞州沃爾瑟姆, March 26, 2026 (GLOBE NEWSWIRE) -- 維泰瑞隆是一家處於臨床階段的全球化生物科技公司，致力於開發用於治療神經退行性疾病、炎症免疫性疾病、代謝性疾病以及罕見病的變革性療法。公司今日宣佈，雲鋒基金董事總經理王舒展已正式加入公司董事會。王先生擁有深厚的投資與營運領導經驗，推動了多家生命科學企業的成長。 ...
March 26, 2026 09:23 ET | Source: Sironax USA, Inc.

更正 -- 维泰瑞隆宣布委任王舒展先生为董事会董事

马萨诸塞州沃尔瑟姆, March 26, 2026 (GLOBE NEWSWIRE) -- 维泰瑞隆是一家处于临床阶段的全球化生物科技公司，致力于开发用于治疗神经退行性疾病，炎症免疫性疾病，代谢疾病以及罕见病的变革性疗法。公司今日宣布云锋基金董事总经理王舒展已正式加入公司董事会。王先生拥有深厚的投资与运营领导经验，推动了多家生命科学企业的成长。 ...
March 26, 2026 09:23 ET | Source: Polyrizon Ltd.

Polyrizon Provides 2025 and Recent Highlights

Raanana, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective...
March 26, 2026 09:15 ET | Source: Edesa Biotech, Inc.

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
March 26, 2026 09:15 ET | Source: Neion Bio, Inc.

Neion Bio Emerges from Stealth with Multi-Product Biosimilar Partnership Leveraging Its Cutting-Edge Genetic Engineering Platform

Neion Bio exits stealth with first biosimilar co-development and supply partnership, leveraging its genetic engineering platform to enable scalable, lower-
March 26, 2026 08:48 ET | Source: BiomX

BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

NETANYA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) today announced the launch of X Security & Defense LTD., a new wholly-owned subsidiary. The company will...